Executive Roundtable: Navigating the FDA's Laboratory Developed Tests Regulation Webinar

April 29, 2024
Pharma & Biotech

This webinar was recorded on Tuesday, 23rd April 2024.

A digital executive roundtable discussion of DeciBio's white paper "Regulatory Reckoning: Navigating the FDA's Laboratory Developed Tests Regulation". Free download available here.

Meet the authors of the white paper, DeciBio's co-founding partner, Dr. Stephane Budel, and Senior Advisor, Dr. Maximillian Schmid as they moderate a discussion with different stakeholders across the ecosystem.

Our invited stakeholders bring a diverse perspective on the matter:

  • Legal
  • FDA Strategy
  • Reimbursement
  • Validation


  • Shannon Bennett, Director of Regulatory Affairs, Mayo Clinic
  • Sarah Clancey Overton, Senior Director of Revenue Cycle Management, Velsera
  • Jon Harol, President & Founder, Lighthouse Lab Services
  • Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates LLC
  • Paul Gadiock, JD, Partner, McDermott Will & Emery
  • Mike Ryan, JD, Partner, McDermott Will & Emery

Moderator + Hosts:

  • Megan Nacar, VP of Commercial, DeciBio Consulting
  • Stephane Budel, PhD, Partner, DeciBio Consulting
  • Maximilian Schmid, MD, Senior Advisor, Independent Consultant

View the webinar recording and slides below:

view the webinar recording

download the slides
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch